FindTrial
Sign In

Role of Miasmatic Diagnosis in the Homoeopathic Management of Acid Reflux Disease (GERD)

TO UNDERSTAND THE MIASMATIC BACKGROUND OF GASTRO OESOPHAGEAL REFLUX DISEASE (GERD) AND ITS HOMOEOPATHIC MANAGEMENT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099754
Enrollment
30
Registered
2025-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K21- Gastro-esophageal reflux disease

Interventions

Intervention1: HOMOEOPATHIC ANTI-MIASMATIC MEDICINES ACCORDING TO EACH INDIVIDUAL CASE: EACH INDIVIDUAL PATIENT WILL BE GIVEN HOMOEOPATHIC ANTI-MIASMATIC TREATMENT ACCORDING TO THEIR MIASMS. THE POTEN

Sponsors

DR DARSHAN JADAV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ALL AGE GROUPS (CHILDREN, ADULTS, ELDERS) AND BOTH SEXES WITH CINICALLY PRE-DIAGNOSED CASES OF GASTRO OESOPHAGEAL REFLUX DISEASE (GERD). 2. CASES WITH FUNCTIONAL CHANGES OR WITH REVERSIBLE PATHOLOGY. 3. PATIENTS WHO HAVE WILLINGNESS TO PARTICIPATE.

Exclusion criteria

Exclusion criteria: 1. THE CASES WITH ACUTE EMERGENCY, CONGENITAL ANOMALY, SEVERE SYSTEMIC ILLNESS AND SEVERE IRREVERCIBLE PATHOLOGICAL CHANGES. 2. THE CASES WHICH DID NOT MAINTAIN A REGULAR FOLLOW UP.

Design outcomes

Primary

MeasureTime frame
GERD Q SCORE SYSTEMTimepoint: AT BASELINE AND AT THE END OF THE TREATMENT AS PER REQUIREMENT OF THE CASE—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR RANJIT SINGH BEDWAN

BARODA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

rsbedwan@gmail.com9825027298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026